Image by Christiana Care via Flickr Exact Sciences has been on fire lately. I do think that the stock will dilute in the next few weeks but I could be wrong. They will need to recoup some of their capital from their clinical trials debt that they have accrued. Exact Sciences is a very explosive stock that could really go higher than expected. Who Knows? I really like the options for Exact Sciences growth in 2011 and beyond. In 3 Months Exact has gone from 3.46 to 8.88, a gain of 158.89%. I expect it to drop down a bit and would suggest any future purchase of shares to come down a bit with a Limit Order. Buy Exact at some form discount at these very hyped up increased levels. But they might not come down and you should buy some at the current Market Price. Wikinvest---Exact Sciences (EXAS)
Google Finance--Exact Sciences (EXAS)
Biotech Stock Mailbag: Exact Sciences
BOSTON (TheStreet) -- Did you catch Jim Cramer's excellent Mad Money segment Wednesday on Exact Sciences(EXAS_)?
If not, a question from Paul P. on the colon cancer diagnostic stock kicks off this week's Biotech Stock Mailbag: "Have you followed and/or have any thoughts on Exact Sciences? I've been following it and am hearing that it may be overhyped. Your thoughts would be appreciated."
